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Charlottesville, Virginia 22908, USA.extracellular matrix (ECM) present in migratory pathways. While proteolytic
activity is likely to contribute to the regulation of neural crest-cell adhesion
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Results: Using a tissue transplantation technique, we show that Xenopus
Received: 15 January 2001CNC cells overexpressing wild-type ADAM 13 migrate along the same Revised: 17 April 2001
hyoid, branchial, and mandibular pathways used by normal CNC cells. In Accepted: 30 April 2001
contrast, CNC cell grafts that express protease-defective ADAM 13 fail to
migrate along the hyoid and branchial pathways. In addition, ectopic Published: 26 June 2001
expression of wild-type ADAM 13 results in a gain-of-function phenotype
Current Biology 2001, 11:918–930in embryos, namely the abnormal positioning of trunk neural-crest cells. We
further show that explanted embryonic tissues expressing wild-type, but not
0960-9822/01/$ – see front matterprotease-defective, ADAM 13 display decreased cell-matrix adhesion.
 2001 Elsevier Science Ltd. All rights reserved.Purified ADAM 13 can cleave fibronectin, and tissue culture cells that
express wild-type, but not protease-defective, ADAM 13 can remodel a
fibronectin substrate.
Conclusions: Our findings support the hypothesis that the protease activity
of ADAM 13 plays a critical role in neural crest-cell migration along defined
pathways. We propose that the ADAM 13-dependent modification of ECM
and/or other guidance molecules is a key step in the directed migration
of the CNC.
Background addition, the segregation of the CNC into well-defined
Cranial neural-crest cells (CNC) are critical for the normal migratory streams in Xenopus has recently been reported
morphogenesis of the head and face in that they give rise to involve ephrin signaling, which is likely to provide
to bone and cartilaginous elements as well as sensory spatial-boundary information critical for directing CNC
neurons, glia, connective tissues, and some muscle. Neu- cells into the branchial arches [7, 8]. While cell surface-
ral crest-cell migration is preceded by an epithelial-mes- associated protease activity is likely to play a role in regu-
enchymal transformation, which results in the emigration lating CNC adhesive and invasive behaviors, there is no
of neural-crest cells from the neural ectoderm or neural direct evidence linking a neural crest-specific protease in
tube. The signals that trigger this transformation and the these processes.
subsequent directional migration of these cells are un-
clear, but changes in neural crest-cell adhesion are pre-
ADAMs are proteins that contain a disintegrin and a met-sumed to play an important part. For example, trunk
alloprotease domain [9]. Of the 31 known ADAMs, 18neural-crest cells have been shown to downregulate
are predicted to be active metalloproteases. Two genericN-cadherin expression [1–4] and to increase their affinity
for ECM molecules as they begin to migrate [5, 6]. In functions have been proposed for ADAM proteases: (1)
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Figure 1 local activation of signaling pathways by the shedding
of cell surface cytokines and growth factors and (2) cell
migration by degradation of the ECM [10, 11]. Although
five ADAMs (numbers 9, 10, 12, 17, and 28) have been
shown to act as metalloproteases in vitro, the only ADAMs
that are known to be catalytically active in vivo are AD-
AMs 9, 10, and 17, which are all involved in shedding/
localized-signaling events. ADAM 9 is responsible for the
shedding of HB-EGF from cultured cells [12]. ADAM 10
(kuzbanian) acts as a sheddase in the Notch signaling
pathway [13–16]. It also appears to function in both axon
extension [17] and axon repulsion [18]. ADAM 10 pro-
motes axon repulsion by releasing (shedding) an ephrin
[18]. Its role (or that of another ADAM or matrix metallo-
protease) in axon extension appears to be as a sheddase
that releases the netrin receptor [19]. ADAM 17 (TACE)
is involved inmultiple ectodomain-shedding events, most
notably the release of tumor necrosis factor [20, 21].
Several observations suggest that ADAMs may function
in cell migration. First, ADAM10 and snake venommetal-
loproteases (SVMPs), the closest ADAM relatives, have
been shown to cleave purified ECM components [22, 23]
and their receptors [24] in vitro. Second, Xenopus ADAM
13 is expressed in cranial neural-crest cells [25], a highly
migratory population of cells that gives rise to a variety
of tissues, including craniofacial cartilage and the cranial
ganglia [26–29]. Third, the secreted ADAM-like gene
product, MIG-17, is required for the proper course of
distal tip-cell migration in C. elegans [30]. Finally, fibro-
blasts use 61 to migrate on a substrate containing the
disintegrin domain of ADAM 9 at a more rapid rate than
they do on a laminin substrate [31].
While these studies point to the likely involvement of
ADAMs in cell migration, there is no direct evidence
linking ADAM protease activity with the adhesive and
migratory behaviors of a specific cell population in vivo.
In this study we show that the metalloprotease activity
Partial protection of the mature ADAM 13 protein is observed with 1
mM TAPI (lane 2). BB-3103 protected ADAM 13 (M) inefficiently
at a concentration of 0.05 mM (lane 3), but it fully protected the mature
form of the protein at concentrations of 0.5 mM (lane 4) and 5.0 mMADAM 13 is a Zn2-dependent metalloprotease. (a) Schematic of the
(lane 5). mAb 9E10 was used for the immunoprecipitation of Myc-processing of ADAM 13 from its full-length 120 kDa precursor (P)
tagged wild-type ADAM 13 from embryo extracts in the presenceto its 100 kDa metalloprotease-active (M) form (1). The second putative
of 0.5 mM BB-3103. After the sample was washed in extraction buffercleavage site between the protease and disintegrin domains is also
containing BB-3103, one half of it was washed in extraction bufferrepresented (2). (b) Western blot of stage 20 embryos extracted in
without the inhibitor. After 2 hrs, Laemmli sample buffer was addedESB buffer in the absence (lane 1) or presence (lanes 2–3) of EDTA.
to both samples, and they were Western blotted with the 9E10Incubation with the 6615F polyclonal antibody (directed against the
antibody (lanes 6 and 7). Both pro and mature forms of ADAM 13ADAM 13 cytoplasmic tail) reveals both precursor (P) and
are visible in the presence of BB-3103 (lane 6), while the maturemetalloprotease-active (M) forms of ADAM 13 after extraction in the
form is degraded after the removal of BB-3103 (lane 7). (d) Westernpresence of 5 mM EDTA (lane 2). A degradation product (arrow)
blot of extracts obtained from noninjected embryos (NI) or fromis detected if the EDTA is added 30 min after extraction. (c) Western
embryos expressing either wild-type ADAM 13 or the catalytic-siteblot of stage 18 embryos expressing Myc-tagged wild-type ADAM
point mutant (E/A) at stage 18. Embryos were processed as in (b)13 detected with the anti-Myc 9E10 mAb. Embryos were
in the absence (-) or presence () of 5 mM EDTA.extracted in ESB buffer containing, as indicated, either no
metalloprotease inhibitor, o-phenanthroline (5 mM), or EDTA (5 mM).
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of ADAM 13 is required for CNC migration. We also alanine for the catalytic glutamic acid renders the protease
inactive.propose that ADAM 13 functions to cleave and remodel
fibronectin and possibly other molecules involved in di-
Overexpression of ADAM 13 affects neural crest-cellrecting CNC migration along defined pathways.
positioning in vivo
ADAM 13 is expressed in Xenopus cranial neural-crest
Results and discussion cells prior to and during their migration [25]. Cranial neu-
Xenopus ADAM 13 is a metalloprotease ral crest (CNC)-cell migration has been described in detail
We previously identified two major forms of ADAM 13 for this species [36]. During neurulation, CNC cells are
in developing Xenopus embryos: a 120 kDa form and a located at the lateral edge of the neural plate. They con-
100 kDa form. By analogy with other ADAMs [32–34], dense to form three segments (mandibular, hyoid, and
these forms almost certainly represent precursor (P) and branchial), each of which migrates as a stream of cells
presumptivemetalloprotease-active (M) forms (Figure 1a) toward the ventral side of the embryo, with the branchial
[25]. If tailbud stage embryos were extracted in a buffer segment further subdividing to yield a total of 4 distinct
containing a nonionic detergent, we observed only the streams (e.g., see Figure 2k,m).
precursor form (Figure 1b). If EDTA was added at the
time of extraction, both the precursor and the presumptive To identify potential ADAM 13 gain-of-function pheno-
metalloprotease-active forms were seen. If EDTA was types in embryos, we overexpressed the protein by in-
added 30 min after extraction, degradation products of jecting synthetic transcripts encoding Myc-tagged wild-
the presumptive metalloprotease-active form became ap- type ADAM 13 into the animal pole of one blastomere
parent (Figure 1b, arrow). The presumptive metallopro- at the two-cell stage. These injections resulted in the
tease-active form is protected by the metalloprotease in- overexpression of ADAM 13 in CNC and also ectopic
hibitors o-phenanthroline, TAPI [20], and BB-3103 [35]. expression of the protein in the neural tissue and the
TAPI and BB-3103 are both hydroxamates that inhibit surrounding epidermis. The protein was rarely expressed
ADAM and matrix metalloproteases; in this system BB- in mesodermal derivatives, and this finding suggests that
3103 appears to be more potent (Figure 1c). These data the mRNA did not diffuse far from the site of injection.
suggest that there is a Zn2-dependent metalloprotease ThemarkerXslug [37] was then used for the identification
activity in the embryo extracts that degrades the presump- of the cranial and trunk crests at various stages of develop-
tive metalloprotease-active form of ADAM 13 but leaves ment. The uninjected side of each embryo (Figure 2)
intact the Pro form. If ADAM 13 was immunoprecipitated served as a control in each of these experiments. At late
and washed in the presence of 1 mM BB-3103, both forms gastrula and early neurula stages, no alterations in the
were retained (Figure 1c, lane 6). If the BB-3103 inhibitor pattern of Xslug expression were noted (Figure 2b). This
was then washed away from the immunoprecipitate, the indicates that the early formation of the neural crest was
mature form disappeared (Figure 1c, lane 7). This shows unaffected by over-/ectopic expression of ADAM 13. In
that the proteolytic activity is directly linked to ADAM contrast, at tailbud stages the normally clearly segmented
13 and is probably not due to another protease(s) present pattern of the CNC into mandibular (m), hyoid (h), and
in the detergent extract.
branchial (b) streams (Figure 2e, arrows) was replaced by
a single mass of cells adjacent to the neural tube on the
injected side (Figure 2d–f, red arrowheads). Ectopic is-To test further whether ADAM 13 proteolytic activity is
lands of cells expressingXslugwere also noted in the trunkinvolved in the observed degradation of the M-form (Fig-
region along the entire anterior-posterior axis (Figure 2d,e,ure 1b,c), we engineered a pointmutation in the active site
blue arrowheads). These displaced cells do not expressof the ADAM 13 metalloprotease domain; the catalytic
the CNC-specific marker Xtwist [38], and this observationglutamic acid (E) was changed to an alanine (A). Neurula-
indicates that over-/ectopic expression of ADAM 13 doesstage embryos expressing wild-type ADAM 13 and the
not respecify trunk crest cells as cranial-crest cells (FigureE-to-A mutant (E/A) were then extracted in nonionic
2j). Instead, these cells (Figure 2d,e, blue arrowheads)detergent. As seen above with embryos expressing wild-
type ADAM 13, the 100 kDa presumptive metallopro- likely represent trunk neural-crest cells that have either
tease-active form (M) was only seen if the extracts con- emerged prematurely from the neural tube or that have
tained EDTA. With embryos expressing the E/A mutant, failed to reach the midline because they were released
however, the 100 kDa mature form was detected whether from the neural epithelium during neural-tube closure.
the embryos were extracted in the presence or absence
of EDTA (Figure 1d). This result shows that the E/A Overexpression in Xenopus of ADAM 9 (Dr. Carl Blobel,
personal communication) does not appear to affect neuralmutant does not self degrade in detergent extracts like
the wild-type ADAM 13 protein does. Collectively, these crest-cell development in this manner, as is evidenced by
staining for Xslug. These findings indicate that the neural-findings (Figure 1) indicate that ADAM 13 is a Zn2-
dependent metalloprotease and that substitution of an crest alterations discussed above are specific to ADAM
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Figure 2 13 and are not likely to be a general consequence of
overexpressing any ADAM with an active metallopro-
tease.
ADAM 13 metalloprotease activity is required
for cranial neural crest-cell migration
In contrast to the amalgamated appearance of the cranial
crest in embryo halves overexpressing wild-type ADAM
13 (Figure 2d–f, red arrowheads), the three streams of
CNC remained well resolved in embryo halves injected
with the protease-defective E/A point mutant (Figure
2g,h). In most embryo halves expressing a protease-defec-
tive ADAM 13, however, it appeared that there was a
reduction in the extent of ventrolateral migration of the
CNC streams, particularly of the hyoid and branchial seg-
ments (Figure 2h). In addition, ectopic islands of Xslug-
stained cells were never observed in the trunks of embryo
halves that express protease-defective E/A ADAM 13
(Figure 2g,h). This indicates that the observed displace-
ment of the trunk neural-crest cells in wild-type ADAM
13-injected embryos is dependent on ADAM 13 metallo-
protease activity. As with wild-type ADAM 13, there were
no differences noted in patterns of Xslug expression in
embryos expressing E/A ADAM 13 at the early neurula
stage (Figure 2c).
We determined that embryo-to-embryo variability in the
severity of inhibition of cranial-crest migration following
E/A ADAM 13 expression was probably due to variable
amounts of E/A protein expressed at the cell surface. To
increase the expression of this mutant construct at the
cell surface, we exploited an observation that deletion of
the cytoplasmic tail from ADAM 13 augments its surface
expression by approximately 8-fold (data not shown), as
has similarly been reported recently for ADAM 12 [39].
Indeed, the injection of synthetic transcripts encoding a
protease-defective, cytoplasmic tail-minus version of
ADAM 13 (E/A Cyto) produced a similar, but reproduci-
Overexpression of ADAM 13 alters neural crest-cell positioning in vivo. bly more pronounced, shortening of cranial neural crest-
Embryos were injected into the animal pole of one blastomere at the cell streams, particularly of the hyoid and branchial seg-
two-cell stage with (b,d–f,j,k) 1 ng wild-type ADAM 13, (c,g,h,l,m) ments (Figure 2i). Importantly, neither E/A ADAM 13the E/A point mutant, or (i) the E/ACyto transcripts. Injected
nor E/A Cyto ADAM 13 had any apparent effect onembryos were cultured to (a–c) early-neurula stage 13 or (d–m) tailbud
stages and processed for (a–i) Xslug mRNA expression (blue), (j–m)
Xtwist, and the Myc-tag epitope (light brown). The green dot indicates
the injected side of each embryo; red and blue arrowheads indicate
pattern and position of the trunk crest is normal, although subtlethe cranial and trunk crests, respectively. Dorsal views of (a)
differences in the cranial crest are observed; (h) the extent ofnoninjected control embryos, (b) wild-type embryos, or (c) E/A
migration of cranial crest segments on the injected side is decreasedmutants at stage 13 show no difference in the Xslug expression pattern.
relative to that of the control side (red arrows). (i) Stronger defects are(d) Dorsal views of wild-type transcript-injected stage 25 (left) and
observed in embryos overexpressing the E/ACyto protein. (j–m)22 (right) embryos. (e) A higher-magnification view of the stage 22
Lateral views of tailbud stage embryos injected with wild-type ADAMembryo in (d) shows that the three cranial-crest segments visible
13 (j,k) or the E/A mutant (l,m). Injected embryos were stained withon the control side (mandibular, m; hyoid, h; and branchial, b) appear
the cranial neural crest-cell marker Xtwist. As seen with Xslug, theas a single mass on the injected side (red arrowhead). (d,e) Islands
cranial-crest segments of the embryo injected with wild-type ADAMof ectopic Xslug- positive trunk crest cells (blue arrowheads) are also
13 are not as clearly defined as those in the contra-lateral noninjectednoted in the flank on the injected side. (f) A horizontal section of a
side (compare [j] and [k]). Interestingly, overexpression of the E/Astage 24/25 embryo confirms the location of the cranial crest
ADAM 13 (compare [l] and [m]) has dramatically reduced theexpressing Xslug on the injected side. Xslug expression in the head
migration of cells from the hyoid and branchial crest segments (redis weak at this stage, as seen in the noninjected control side (e.g.,
arrowhead).stage 25 embryo on the left in [d]). (g) Dorsal views of tailbud embryos
(stage 24, left; stage 22, right) expressing the E/A point mutant. The
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Figure 3tissues, including the trunk crest, that do not normally
express ADAM 13 (Figure 2g–i). Collectively, the results
presented in Figure 2g–i suggest that metalloprotease-
defective constructs of ADAM 13 act in a dominant-nega-
tive fashion to yield a cranial crest-specific loss-of-function
phenotype, the inhibition of CNC-cell migration.
To determine whether the E/A mutant could indeed in-
terfere with wild-type ADAM 13 proteolytic activity, as
suggested by both the CNC-cell phenotype (Figure 2)
and by published data on ADAM 10 [15], we have used
a simple and well-defined gain-of-function phenotype in-
duced by wild-type ADAM 13 overexpression and tested
the ability of the E/A mutant to rescue this effect. As
previously described [40], ADAM 13 overexpression (0.5
ng) induces cement gland expansion in 29% (n  78) of
injected embryos. This phenotype is directly linked to the
metalloprotease activity of ADAM 13 since no embryos
injected with the E/A point mutant exhibited expanded
cement glands. In contrast, when the same amount of
wild-type transcript was coinjected with E/A ADAM 13
(0.5 ng), only 11% (n  85) of the embryos displayed
altered cement glands. This result shows that the E/A
mutant can interfere with wild-type ADAM 13 proteolytic
activity and further suggests that this mutant can act as a
dominant negative. Similar dominant-negative properties Overexpression of ADAM 13 does not affect central nervous-system
were also observed in additional experiments, as de- formation. Whole-mount in situ hybridization of embryos expressing
(a,c,d) wild-type ADAM 13 or (b,e) the E/A mutant constructs werescribed below (see Figure 7).
processed with (a–c) the pan-neural marker Xsox-2 and (d,e) the
neuronal marker N-tubulin. Black dots indicate the transcript-injected
To test whether over-/ectopic expression of ADAM 13 half of each embryo. Embryos expressing wild-type ADAM 13 lack
affects neural crest-cell behavior and not merely the ex- Xsox-2-positive cells in the vicinity of the otic vesicle; (a–c) such cells
are present in the E/A and noninjected control halves of each embryopression pattern of Xslug, we repeated the injections of
(arrowheads). (c) Transverse section at the level of the putative oticwild-type and E/A ADAM 13 and stained for the CNC-
vesicle of an embryo in a stage similar to that in (a). Dorsal views
cell marker Xtwist [41]. As seen for Xslug, in embryos that of both (d) wild-type and (e) E/A-expressing embryos at the early-
neurula stage (stage 15). (d,e) Lateral expression of N-tubulin withinoverexpress wild-type ADAM 13, the three initial CNC
the putative trigeminal ganglion (black arrowheads) is absent from (d)segments appear to merge, as is evidenced by staining
the wild-type-injected side. (f–i) Dorsal views of neurula-stage (stagefor Xtwist (Figure 2j). In contrast, the uninjected side of 19) embryos overexpressing (f,g) wild-type or (h,i) E/A ADAM 13 and
the same embryo was not affected (Figure 2k). More hybridized with the Xkrox-20 probe. The localization of Xkrox-20 in
rhombomeres 3 and 5 is identical in the uninjected control sidesignificantly, staining of embryos expressing E/A prote-
compared to the injected side of each embryo.ase-defective ADAM 13 for Xtwist revealed a strong retar-
dation in the progression of the hyoid and branchial CNC
streams (Figure 2l), and this finding reinforces the pro-
posal that protease-defective forms of ADAM 13 can act wild-type ADAM 13; Figure 2d–f,j) and loss-of-function
in a dominant-negative fashion in CNC cells. Migration (with protease-defective ADAM 13; Figure 2g–i,l) effects
on an ADAM 13-driven process in neural-crest cells. Anof the posterior margin of the manbidular CNC stream
alternate possibility is that the observed changes are andid not appear to be affected by E/A ADAM 13 expres-
indirect consequence of disruptions in general neural pat-sion, and this finding suggests that an alternate, possibly
terning or the result of alterations in normal neural crest-compensatory, mechanism is able to promote the migra-
cell proliferation and/or specification. We conducted twotion of these particular cells when ADAM 13 function is
sets of experiments to consider these possibilities.perturbed.
First, we stained for the neural markers Xsox-2 [37, 42]Effects of ADAM 13 over-/ectopic expression
are specific to the neural crest and N-tubulin. Xsox-2 is expressed in the entire central
We interpret the results presented in Figure 2 as evidence nervous system, while N-tubulin is restricted to future
that the observed perturbations of CNC cells in embryos neurons. In embryo halves expressing wild-type (Figure
3a,c, black dot) or E/A (Figure 3b, black dot) ADAMexpressing ADAM 13 are due to gain-of-function (with
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13, staining for Xsox-2 was similar to that observed in is consistent with a model in which the normal function
of ADAM 13 is to promote neural crest-cell migration. Weuninjected control halves, with the exception of a lateral
spot of staining at the level of the otic vesicle that was further propose that overexpression of protease-defective
ADAM 13 impedes the normal progression of the CNCabsent in embryo halves injected with wild-type ADAM
13 (Figure 3a,c). This suggests that, aside from the otic cells by interfering with endogenous ADAM 13 metallo-
protease activity. These experiments do not allow us toplacode, neural development appeared normal in ADAM
distinguish, however, whether the results observed are13 transcript-injected embryos. Similarly, in situ hybrid-
due to a direct effect on the migration of neural-crest cellsization with N-tubulin at the neural plate stage revealed
or whether an indirect effect on surrounding tissues leadsa normal pattern of stripes for primary neurons in embryo
to a subsequent perturbation of migration pathways. Tohalves expressing wild-type (Figure 3d, black dot) or E/A
minimize the possible effects of ADAM 13 (ectopic) ex-(Figure 3e, black dot) ADAM 13. As observed for Xsox-2,
pression in surrounding non-CNC tissues, we grafteda lateral spot of expression (Figure 3d,e, arrowheads, unin-
CNC cells [45] from neurula-stage embryos (stage 18)jected side) at the level of the trigeminal ganglion [43]
injected with GFP alone or together with either wild-was absent in embryo halves injected with wild-type but
type or E/A ADAM 13 (donor) into uninjected siblingnot E/A ADAM 13 (compare Figure 3d,e, injected sides).
(host) embryos (Figure 4). Our results show that graftedThe failure of E/A ADAM 13 to affect primary neurogen-
CNC cells coexpressing GFP with wild-type ADAM 13esis (Figure 3e) is in contrast to the effects reported by
migrate toward the ventral side of the embryo with thePan and Rubin for a similar mutant of ADAM 10, which
same timing and in the same segmental pattern (Figurewhen expressed in Xenopus leads to increased neurogen-
4a) as CNC cells expressing GFP alone (data not shown).esis and expansion of N-tubulin staining [15]. We also
This suggests that the “fusion” of the CNC segmentsused the Xenopus Krox-20 probe to analyze the segmental
observed in embryos overexpressing wild-type ADAM 13organization of the hindbrain in embryos overexpressing
(Figure 2d,e) may be due to the ectopic expression (e.g.,wild-type and E/A ADAM 13 [44]. In embryos injected
in the ectoderm) of the protein rather than a functionwith wild-type (Figure 3f,g) or E/A ADAM 13 (Figure
of ADAM 13 overexpression within the CNC cells. In3h,i), Krox-20 expression in rhombomeres 3 and 5 was at
contrast, the migration of CNC cells expressing the E/Athe same anterior-posterior position in the injected versus
ADAM 13 was severely impaired. These cells often re-noninjected sides of each embryo. These results show
mained at the site of initial placement of the graft (Figurethat the anterior-posterior patterning of the neural tube
4b). In some embryos migration was observed in theis not affected by the ectopic expression of wild-type and
mandibular segments (Figure 4c). Whole-mount immu-E/A ADAM 13 proteins.
nostaining with the 9E10 anti-Myc mAb confirmed that
these cells also expressed the Myc-tagged E/A ADAM 13In a second set of experiments, we tested whether overex-
protein (data not shown). This observation is in accordpression of wild-type or E/A ADAM 13 affects neural
with previously described experiments in which Xtwistcrest-cell proliferation and/or differentiation, which would
staining of the mandibular CNC segment was observedbe reflected in changes in levels of neural crest-cellmarker
in embryo halves expressing the E/A mutant (Figure 2l).genes. Levels of Xslug and Xtwist mRNAs in embryos
expressing wild-type ADAM 13 or the E/A mutant were
These data suggest that ADAM 13 metalloprotease func-quantified by dot blot hybridization at early, mid, and
tion is essential for CNC migration in the hyoid andlate neurula stages and compared to those of uninjected
branchial segments but not for cell migration in the man-controls. In these quantitative experiments, no statisti-
dibular segment. Time lapse movies of grafted embryoscally significant differences in the expression of these
show that fluorescent CNC cells expressing the E/A mu-neural-crest markers were observed (data not shown).
tant tend to migrate anteriorly to the mandibular pathwayThese results suggest that the apparent increase in the
or posteriorly to the vagal pathways rather than enter theXslug signal observed with in situ hybridization at the
hyoid and branchial pathways (example movies may belevel of the CNC likely represents abnormal positioning
found at http://faculty.virginia.edu/desimonelab/). Theserather than an increased number of neural-crest cells.
results demonstrate that ADAM 13 metalloprotease func-
tion is required by CNC cells to permit their migrationADAM 13 function is required for cranial neural
crest-cell migration through these pathways. Why the migration of CNC cells
expressing E/A ADAM 13 is restricted to the mandibularBased on the results presented in Figures 2 and 3, we
conclude that over-/ectopic expression of ADAM 13 con- pathway is unclear at present. It may be that migration
through the hyoid and branchial arches requires the pro-structs primarily affected neural crest-cell migration and
not neural-crest growth and/or differentiation. Ectopic ex- teolytic processing of ECM molecules, which otherwise
restrict the passage of these cells (see below). Becausepression of wild-type ADAM 13 results in the appearance
of trunk neural-crest cells in the lateral pathway, where the developing optic vesicle creates a “bulge” that may
serve to physically separate the overlying ectoderm fromthe migration of these cells is normally restricted. This
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Figure 4 the labeled graft. Endogenous ADAM 13-dependent pro-
teolytic activity associated with these wild-type “pioneer”
cells may have been sufficient to open the mandibular
pathway and may have thus allowed grafted E/A-express-
ing CNC cells to follow.
ADAM 13 alters cell adhesion on fibronectin
Taken together, the results presented in Figures 2–4
strongly suggest that ADAM 13 plays a critical role in
CNC-cell migration in vivo. In order to address how this
protein might affect cell migration, we have used two in
vitro assays. The first one addresses the adhesion and
migration capacity of mesodermal cells expressing ADAM
13 on a fibronectin substrate. These cells were chosen
because they do not express detectable levels of ADAM
13 and because theymigrate in a predictable fashion under
these conditions [46]. Animal caps expressing either wild-
type or the protease-defective E/A form of ADAM13were
dissected from mid-blastula stage embryos and placed on
fibronectin substrates in the presence of the mesoderm-
inducer activin-A (Figure 5). Under these conditions, non-
injected control caps attached to the substrate and under-
went convergence-extension movements (Figure 5a).
Cells in contact with the substrate at the periphery of the
explant sent out lamellapodial extensions and spread and
migrated as a cohesive sheet. Animal cap explants express-
ing wild-type ADAM 13 underwent convergence-exten-
sion movements, but cells in contact with the substrate,
while remaining adherent, rounded-up, lost contact with
their neighbors, and dispersed (Figure 5b,c). This change
in behavior was dependent on themetalloprotease activity
of ADAM 13. When explants expressing ADAM 13 were
cultured in the presence of the metalloprotease inhibitorCNC grafts. Transcripts encoding GFP (0.3 ng) alone or in combination
BB-3103, the number of dispersed and rounded cells aswith wild-type (0.7 ng) or E/A (0.7 ng) ADAM 13 were injected in
one blastomere of two-cell-stage embryos. Labeled cranial neural- well as the extent of cell dispersion decreased signifi-
crest explants were taken from stage 17–18 Xenopus embryos and cantly, while adherent cells spread to the same extent as
grafted into unlabeled sibling embryos at the same position (CNC was
their noninjected counterparts (Figure 5d). In addition,removed from the host at this position). Lateral views of tailbud stage
extensive cell rounding and dispersion were rarely ob-(stage 24) grafted embryos, with (a–c) bright field images on the left
and (a–c) fluorescent images on the right. (a,a) Embryos that served with animal caps expressing either the E/A point
were grafted with cranial-neural crest that expressed both GFP and mutant ADAM 13 (Figure 5e,f) or ADAM 10 (H.C. and
wild-type ADAM 13 were indistinguishable from (not shown)
D.A., unpublished data).embryos grafted with CNC expressing GFP alone. (a) Fluorescent
neural-crest cells migrate along pathways normally used by CNC
streams (m, mandibular; h, hyoid; ba, branchial anterior; bp, branchial The idea that the ADAM 13 protease can affect cell-
posterior). (b–c) In contrast, cranial neural-crest cells expressing both adhesive contacts is further suggested by the observationthe E/A ADAM 13 mutant and GFP (b) do not migrate or (c) only
that over-/ectopic expression of wild-type but not E/Amigrate in the mandibular segment. The cement gland (dotted line)
and (e) the future eye are used in each embryo as reference points ADAM 13 often leads to ectodermal blistering [40], a
for the evaluation of neural crest-cell position and the extent of behavior attributed to decreased contact between the ec-
migration. toderm and underlying tissue or ECM. Decreased contact
between the ectoderm and the underlying tissue [40] may
also explain several of the other phenotypes observed
following ADAM 13 over-/ectopic expression (Figure 3).the underlying mesenchymal tissue in the vicinity of the
For example, both placodal induction and cement glandmandibular stream, it is possible that sufficient “space”
specification require specific positive and negative signal-is available to permit CNC-cell passage. Alternatively,
ing between the ectoderm and the underlying tissuebecause the mandibular segment is the first to initiate
[47–49]. ADAM 13 over-/ectopic expression may physi-CNC-cell migration, cells in this segment may not have
all been removed from the host embryos prior to receiving cally interfere with these signals by decreasing cell-cell
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Figure 5
Ectopic expression of ADAM 13 causes
perturbation of cell spreading on fibronectin.
Animal cap explants expressing (b–d) wild-
type ADAM 13 or (e,f) the protease-defective
E/A point mutant were cultured on fibronectin
substrates in the presence of 20 U/ml activin-
A. (a) Under these conditions, noninjected
explants undergo convergence extension
movements (arrow), while cells in contact with
the substrate spread and migrate away from
the explant as a cohesive sheet. (b) Explants
expressing wild-type ADAM 13 also undergo
convergence extension movements (arrow),
but (b,c) the cells in contact with the
substrate are round and dispersed. These cells
remain viable during the course of the assay
as determined by trypan blue exclusion (data
not shown). (d) Extensive cell spreading
occurs in cap cell explants expressing wild-
type ADAM 13 in the presence of 0.25 mM
BB-3103 protease inhibitor. (e,f) Cell
spreading is also observed in animal cap
explants expressing the protease-defective
E/A mutant construct. (c,f) Higher-
magnification views of explants in (b) and (e),
respectively. (a,b,d,e, arrows) Converging
and extending explant tissue above the plane
of focus. The scale bars in (e) and (f)
represent 1 mm.
contacts. Interestingly, experimental separation of the active form of wild-type ADAM 13 is expressed at the
cell surface (Figure 7b, right). This is also the case forouter from the inner ectodermal layer by dissection is
the E/A point mutant (Figure 7b, right). Nontransfectedsufficient to induce cement gland markers [50]. In our
cells placed on a fluoresceinated fibronectin substrate ad-case, ADAM 13 over-/ectopic expression may recapitulate
hered and spread rapidly (Figure 6a). After 14 hr, thethis dissection in vivo at a cellular level. Similarly, ADAM
fluorescent substrate was mostly intact (Figure 6a). In13 over-/ectopic expression may block a positive signal
contrast, transfected cells expressing high levels of wild-necessary for the induction of the trigeminal ganglion and
type ADAM 13 (Figure 6b) modified extensively the fi-the formation of the otic placode [51].
bronectin substrate (Figure 6b). Alteration of the fibro-
nectin substrate depended on the proteolytic activity ofADAM 13 can remodel a fibronectin substrate
and can cleave fibronectin ADAM 13 because transfected cells expressing similar or
As indicated by the animal cap results, ADAM 13 overex- higher levels of E/A ADAM 13 (Figure 6c and 7b) did
pression in a migrating population of cells can lead to not lead to removal of the fibronectin substrate (Figure
reduced adhesion to the substrate and rounding-up. This 6c) but instead reproducibly demonstrated increased
could result either from perturbing cell surface integrins “protection” compared to nontransfected cells (Figure
and/or by affecting the ECM. We next asked whether 6a). In fact, nontransfected XTC cells appreciably re-
ADAM 13 can modify a fibronectin substrate. We plated model the fluorescent fibronectin when left for an addi-
Xenopus XTC cells transfected with ADAM 13 on a fluo- tional 10–12 hr (Figure 7a, arrowheads 1 and 2). Under
rescently labeled fibronectin substrate and observed the these conditions XTC cells overexpressing the E/A mu-
cultures after 14 hr by epifluorescence microscopy. Non- tant did not remodel the fibronectin substrate (Figure
transfected XTC cells express low levels of ADAM 13 at 7a, arrowhead 3), and this finding further demonstrates
their surfaces (Figure 6a and data not shown). Transient that this protein can inhibit endogenous ADAM 13 func-
transfection with Myc-tagged wild-type or mutant forms tion by acting as a dominant negative.
of ADAM 13 resulted in expression of additional ADAM
13 protein at the cell surface (Figure 6b and 7b). Wild- To test whether ADAM13 can cleave fibronectin directly,
type ADAM 13-transfected XTC cells express both the we immunoprecipitated fibronectin from Xenopus plasma
120 kDa precursor (P) and the 100 kDa metalloprotease- by using the 4H2mAb [46] and combined it with immuno-
active (M) forms (Figure 7b, left). Biotinylation experi- precipitated ADAM 13 in the absence (Figure 7c, lane 1)
or presence (Figure 7c, lane 2) of the metalloproteasements confirmed that only the 100 kDa metalloprotease-
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Figure 6 Figure 7
The E/A ADAM 13 inhibits endogenous ADAM 13 remodeling of
fibronectin. Xenopus XTC cells were plated on fluorescent
Xenopus XTC cells transfected with wild-type ADAM 13 remodel a fibronectin for 24 hr prior to fixation. (a) Cells expressing the E/A
fibronectin substrate. Xenopus XTC cells were plated on fluorescent ADAM 13 were detected with the 9E10 mAb. Fields containing
fibronectin for 14 hr prior to fixation. Cells were permeabilized and both transfected (arrowhead 3) and nontransfected (arrowheads 1
processed for immunofluorescence with a mouse polyclonal antibody and 2) cells were selected. The fluorescent fibronectin substrate
directed against (a) endogenous Xenopus ADAM 13 or (b–c) mAb within the same field is presented in (a). (a) During this longer period
9E10 directed against the Myc-tag epitope. Fluorescence was of incubation (24 hr), nontransfected cells remodeled the substrate
(arrowheads 1 and 2), while the cell expressing the E/A ADAM 13observed with a confocal microscope. (a–c) Fluorescent fibronectin
did not (arrowhead 3). (b) Surface-biotinylated XTC cells transfectedsubstrates correspond to the same fields as (a–c) immunostained
with either wild-type or E/A ADAM 13 were extracted andcells. (a) Endogenous ADAM 13 is preferentially localized to the
immunoprecipitated with mAb 9E10. Immunoprecipitated proteinsperinuclear endoplasmic reticulum and to cellular extensions at the
were separated by SDS-PAGE and transferred to nitrocellulose. Blotscell periphery in nontransfected XTC cells (arrowheads). (a) These
were either incubated in mAb 9E10 for the detection of total ADAMcellular extensions colocalize with minor alterations in the fluorescent
13 protein (left panel) or in streptavidin-HRP for the identification offibronectin substrate (arrowheads). (b) Cells transfected with wild-
ADAM 13 at the cell surface (right panel). In each case only thetype ADAM 13 dramatically modified (b) the substrate. In contrast,
mature form (M) of wild-type ADAM 13 or the E/A mutant is present(c) the fluorescent fibronectin substrate in contact with (c) E/A-
at the cell surface. (c) Embryos overexpressing wild-type ADAM 13transfected cells is comparable to the substrate of (a)
were extracted in the presence of BB-3103. Immunoprecipitated wild-nontransfected control cells.
type ADAM 13 was incubated with immunoprecipitated fibronectin
in the absence (lane 1) or the presence (lane 2) of 0.5 mM BB-3103
for 1 hr at 20C. The immunoprecipitated fibronectin was analyzed
by a Western blot with the 4H2 mAb (left panel). The same blot wasinhibitor BB-3103.While a large fraction of the fibronectin
then probed with mAb 9E10 for the detection of wild-type ADAM
(220 kDa) remained intact under both conditions (arrow- 13 (right panel). The mature (M) form of ADAM 13 is only seen in
head a), a fragment recognized by the anti-fibronectin lane 2, and this observation confirms the efficiency of the BB-3103
inhibitor in these experiments. The arrowheads in the left panel of (c)mAb 4H2 was seen in samples in which the protease
point to intact fibronectin (arrowhead a) or the major specific degradationinhibitor was removed (Figure 7c, lane 1, arrowhead b). product (arrowhead b, 90 kDa). The asterisk points to a 120 kDa
Together, these results indicate that ADAM 13 can re- fibronectin fragment, the formation of which is independent of
ADAM 13.model a fibronectin substrate and can cleave fibronectin
at a preferred site.
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Figure 8 tion of a highly motile population of cells in vivo and that
it may do so by modifying a component of the ECM.
Our results suggest that ADAM 13 may have several spe-
cific functions in cranial neural crest-cell migration (Fig-
ure 8). First, ADAM 13 may help cells detach from the
neuroepithelium by decreasing cell adhesion to the sur-
roundingECM(Figure 8a). Second, ADAM13may cleave
proteins of the ECM and thereby open or widenmigration
pathways (Figure 8b). During their migration, pioneer
neural-crest cells may leave directional clues within the
remodeled ECM so that following cells maymigrate along
the same pathways (Figure 8c).
A model for ADAM 13 function in neural crest-cell migration. (a) Neural- ADAM 13 function in the migrating CNC is likely to
crest cells (black ovals) are initially part of the neural epithelium.
involve the cleavage of proteins present in the branchialExpression of ADAM 13 at the neural crest-cell surface could help
and hyoid pathways. Our data suggest that these proteinsrelease them from their neighbors and/or the surrounding ECM. (b)
Following neural crest-cell release, ADAM 13 metalloprotease activity likely include components of the ECM. In this case, the
may remodel the ECM that lies between the ectoderm and the underlying migration of CNC cells expressing the dominant-negative
mesoderm. This activity may result in the widening of migration
ADAM 13 in the mandibular pathways can be explainedpathways. (c) While the “Pioneer” cells progress through a dense
either by the absence of the “restrictive” ADAM 13 sub-ECM, the “Follower” cells use the open pathways and may respond
to directional clues exposed in the “remodeled” matrix. strate or by the tissue geometry of this particular region.
This apparent requirement for ADAM 13 proteolytic ac-
tivity in the hyoid and branchial segments but not in the
mandibular segment also suggests that ADAM13 function
The ability to remodel a fibronectin substrate is a feature may help to “direct” CNCmigration by unmasking poten-
of a number of cultured cells [52–55]. Interestingly, fibro- tial guidance cues along their migratory routes. Previous
nectin remodeling is also increased after transformation studies in Xenopus have shown that proteins from the
by v-src [56], and increased levels of pp60Src are associ- Ephrin family are involved in restricting the CNC to
ated with matrix remodeling by invadopodia [57, 58]. We specific migratory pathways [7, 8]. Future work will inves-
have recently reported that the ADAM 13 cytoplasmic tigate the possibility that ADAM 13 is involved in this
domain can bind Xenopus Src proteins in vitro [40]. The process, possibly by releasing ephrins, as has been re-
ported for ADAM 10 in axon repulsion [18].results presented in the current study show that ADAM
13 is a metalloprotease expressed by a highly invasive
population of cells in vivo (i.e., CNC cells) and that Conclusion
ADAM 13 has the ability to remodel a fibronectin sub- In summary, overexpression of wild-type ADAM 13 and
strate when expressed in cultured cells. Together, these metalloprotease-defective forms of the protein has pro-
results suggest that ADAMsmay be involved in the acqui- found effects on the behavior of neural-crest cells in early
sition of invasive properties by tumor cells. Future work Xenopus embryos as well as in animal cap explants and
will address the possibility that Src proteins stimulate XTC cells cultured on fibronectin substrates in vitro.
ADAM 13 metalloprotease activity. Grafted CNC cells expressing the E/A “dominant-nega-
tive” ADAM 13 are restricted from the branchial and
hyoid pathways. Our findings are consistent with a model
A model of ADAM 13 function in cell migration in which the ADAM 13 protease functions in neural crest-
Proteins of the ADAM family have been shown to act as cell adhesion and migration. Future work will address
cell adhesion molecules and, through their metallopro- the substrate specificity of the ADAM 13 protease, the
tease domains, as sheddases [10, 11, 59, 60]. It has also relative contributions of ADAM 13 metalloprotease activ-
been proposed that ADAM metalloproteases may pro- ity to matrix remodeling and cell signaling, and the possi-
mote cell migration by degrading the ECM. Such an activ- ble roles of other domains of ADAM 13 (e.g., disintegrin
ity has, however, not been demonstrated in a biologically domain, cytoplasmic tail) in neural crest-cell biology.
relevant context. Although a more distantly related
ADAM-like protein, MIG-17, has recently been shown
Materials and methodsto be involved in charting the course of cell migration in
Egg and embryo preparationC. elegans [30], a potential target(s) of the putative MIG-
Eggs were obtained from adult Xenopus laevis, fertilized, and cultured
17 metalloprotease was not identified. The current study as described previously [25]. Embryos were staged according to Nieuw-
koop and Faber [61].provides evidence that an ADAM is involved in themigra-
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screen for 24–72 hr and then quantified with ImageQuant software (IQTranscript preparation and embryo injection
Mac version 1.2).The full-length coding region of Xenopus ADAM 13 [25] was cloned
into the pCS2 transcription vector [62]. A point mutation substituting
an alanine for glutamic acid 341 in ADAM 13 (E/A) was accomplished Animal cap adhesion/migration assays
with the Stratagene Quick Change mutagenesis kit. Both the full-length Each blastomere at the two-cell stage was injected near the animal pole
wild-type and E/A mutant constructs were also tagged with the Myc with 0.5 ng of synthetic transcripts. At the mid-blastula stage, the animal
epitope at their C-termini so that expression could be followed with the cap regions of injected and noninjected control embryos were dissected
9E10 mAb (Santa Cruz Laboratories). The vector pCS2MycGFP was and placed on fibronectin substrates (20g/ml coating concentration) in
a generous gift from M. Klymkowsky (University of Colorado, Boulder). the presence of 20 U/ml activin-A (kindly provided by D. Gospodarowicz,
It has a single Myc upstream of the GFP and was made by Y. Vourgour- Chiron Corporation) diluted in 60% L15 (Gibco/BRL). In some experi-
akis. All mRNAs were transcribed with SP6 polymerase after linearization ments, explants were cultured in the presence of 0.25 mM of the BB-
of plasmids with Not1 and were prepared for injection as described in 3103 protease inhibitor (British Biotech). Explants were cultured for 18 hr
[40]. Transcripts (0.5 ng or 1 ng total) were injected close to the animal and photographed with a Leica M7Z dissecting scope or by interference
pole region of one blastomere at the two-cell stage in order for the contrast with a Leitz (Fluovert FU) inverted microscope.
targeting of ectoderm/neuroectoderm derivatives. The uninjected half of
each embryo served as a control in all experiments. In some embryos,
XTC cell transfection and fibronectin substrate assaysthe GFP transcript was injected alone as a control for the microinjection
Xenopus XTC cells were grown in 60% L15 supplemented with 10%procedure.
fetal bovine serum, penicillin (10 IU/ml) and streptomycin (100 g/
ml) (Gibco BRL). Cells were transfected with the Fugene 6 reagent
Characterization of ADAM 13 processing (Boehringer-Mannheim) according to the manufacturer’s instructions.
and proteolytic activity Transfected and control cells were grown for 48 hr after transfection,
Injected and noninjected control embryos at neurula stages 18 or 20 detached with cold CMF (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3,
were solubilized in ESB buffer (100 mM NaCl, 50 mM Tris [pH 7.5], 15 mM HEPES [pH 7.6], 1% BSA), and plated on fluorescent fibronectin.
1% NP40, 2 mM PMSF) either in the presence or absence of 5 mM Fluorescent substrata were prepared as described in Avnur and Geiger
EDTA. Solubilized glycoproteins were analyzed by Western blotting with [52], with slight modification. Glass cover slips were coated with 100
the affinity-purified anti-ADAM 13 cytoplasmic-tail antibody (6615F) and g/ml of bovine FN (Sigma) and fluoresceinated with NHS-Fluoresceine
ECL detection (Amersham), as described previously [25]. Embryos in- (Sigma) in 50 mM carbonate buffer (pH 9). Cells were left on fluorescent
jected with 1 ng of transcripts encoding Myc-tagged constructs were fibronectin for 14 hr in complete culture media, fixed with 4% formalde-
extracted in the presence of 5 mM EDTA or in the presence of the hyde in 1	 MBS, permeabilized with 0.5% Triton X-100 in PBS, and
hydroxamate inhibitors TAPI (kindly provided by Dr. Roy Black at Im- incubated in PBS containing 1% BSA and various antibodies. Secondary
munex) or BB-3103 (kindly provided by British Biotech Pharmaceuticals anti-mouse IgG linked to Texas red (Molecular Probes) was diluted in
Ltd.). Extracts were processed as above, but after Western blotting they PBS/1% BSA at 10 g/ml. Cells and substrates were imaged with a
were probed with the 9E10 mAb. Five embryo equivalents per lane of Leica DMRXE confocal microscope (Leica TCS SP, 488/568 nm).
material were analyzed for Western blotting with the 6615F antibody
and 1 embryo equivalent per lane with 9E10. Cell surface labeling of XTC cells was done with EZ-Link Sulfo-NHS-
Biotin (Pierce) in MBS at 1 mg/ml on live adherent cells for 20 min at
room temperature. Biotinylated cells were washed with MBS containingWhole-mount in situ hybridization and immunostaining
100 mM glycine (pH 7.5) and extracted in TBS, 1% Triton X-100, 2 mMWhole-mount in situ hybridization was carried out as described in Harland
PMSF with 5 mM EDTA. Cellular debris was removed by centrifugation at[63] with slight modification [40]. Staining was performed with BM
13,000 rpm at 4C for 15 min. Immunoprecipitations were done exactlyPurple (Boerhinger-Mannheim) overnight at 20C. Embryos were also
as described in [66] with the 9E10 monoclonal antibody (SantaCruzimmunostained with the 9E10 anti-Myc antibody (10 g/ml; Santa Cruz
Laboratory) linked to Protein-G-agarose (Boehringer Manheim). Biotinyl-Biotechnology) as described in Hens and DeSimone [64], with second-
ated proteins were detected with HRP-conjugated Streptavidin (Pierce)ary anti-mouse HRP conjugated-IgG (5 g/ml) and DAB staining. Em-
at 0.2 g/ml in TBS containing 0.1% Tween-20, followed by ECL treat-bryos were then cleared in 1% H2O2 and 0.5% formamide overnight
ment as described above.under strong fluorescent light, dehydrated in 100% methanol, and
mounted in benzyl benzoate/benzyl alcohol (2:1 vol/vol). Representative
embryos were washed in methanol and embedded in polyethylene glycol Cranial neural-crest transplantation
400-distearate (Aldrich), and serial 10 m sections were cut and Two cell-stage embryos injected with untagged-GFP (0.3 ng), GFP
mounted in mowiol. Sense transcripts were used in parallel experiments (0.3 ng) plus wild-type ADAM 13 (0.7 ng), or GFP (0.3 ng) plus E/A
as controls (data not shown). The cDNA templates used for the genera- ADAM 13 (0.7 ng) were cultured to neurula stages (17–18). Cranial
tion of probes were generously provided by the following investigators: neural-crest cells were transplanted from injected neurulae into unin-
Xslug (Roberto Mayor), Xsox-2 (Robert Grainger), XCG (Hazel Sive), jected sibling embryos from which a comparable region of cranial neural-
Xkrox-20 (Thomas Lallier). Xtwist and N-tubulin were obtained by PCR crest had been removed (homotopic and homochronic) as described in
from databank sequences and were cloned with the TOPO-TA cloning [45]. Photographs of transplanted embryos (stage 22–25) were taken
kit (Invitrogen). with a Zeiss dissecting scope equipped for epifluorescence. Immuno-
staining of the Myc-tagged wild-type and E/A ADAM 13 was performed
as described above.RNA spot blots
Total RNA from 10 embryos at various stages was extracted as in [65]
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